All Pharma News
Celyad receives approximately EUR 9.8m in private placement from shareholders

Celyad receives approximately EUR 9.8m in private placement from shareholders
GLOBENEWSWIRE
24 Aug 2023
Share Share
Celyad Oncology announces receipt of Nasdaq delisting notice

Celyad Oncology announces receipt of Nasdaq delisting notice
GLOBENEWSWIRE
15 May 2023
Share Share
Celyad announces receipt of Nasdaq initial notification on ADS bid price

Celyad announces receipt of Nasdaq initial notification on ADS bid price
GLOBENEWSWIRE
24 Apr 2023
Share Share
Celyad Oncology announces receipt of Nasdaq notice

Celyad Oncology announces receipt of Nasdaq notice
GLOBENEWSWIRE
04 Apr 2023
Share Share
Celyad Oncology appoints Georges Rawadi as its new CEO

Celyad Oncology appoints Georges Rawadi as its new CEO
GLOBENEWSWIRE
24 Mar 2023
Share Share
Cash crunches keep Bioasis and Celyad`s feet to the fire

Cash crunches keep Bioasis and Celyad`s feet to the fire
Nick Paul Taylor FIERCE BIOTECH
24 Mar 2023
Share Share
Celyad Oncology reports full year 2022 financial results

Celyad Oncology reports full year 2022 financial results
GLOBENEWSWIRE
23 Mar 2023
Share Share
Celyad to announce full year 2022 financial results and host conference call

Celyad to announce full year 2022 financial results and host conference call
GLOBENEWSWIRE
17 Mar 2023
Share Share
Celyad Oncology announces non-cash impairment

Celyad Oncology announces non-cash impairment
GLOBENEWSWIRE
15 Mar 2023
Share Share
Celyad announces publication of data from its Phase 1 THINK study of CYAD-01

Celyad announces publication of data from its Phase 1 THINK study of CYAD-01
GLOBENEWSWIRE
09 Feb 2023
Share Share